Pulse Biosciences, Inc. SEC filings PLSE

Pulse Biosciences, Inc. has 641 filings in SEC EDGAR's recent list, going back to Nov 13, 2014. Its latest annual report, Form 10-K, was filed on Feb 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K/A Amended annual report Apr 30, 2026 Dec 31, 2025
10-K Annual report Feb 19, 2026 Dec 31, 2025
10-K/A Amended annual report Apr 30, 2025 Dec 31, 2024
10-K Annual report Mar 31, 2025 Dec 31, 2024
10-K Annual report Mar 28, 2024 Dec 31, 2023
10-K Annual report Mar 31, 2023 Dec 31, 2022
10-K Annual report Mar 31, 2022 Dec 31, 2021
10-K Annual report Mar 12, 2021 Dec 31, 2020
10-K/A Amended annual report Mar 31, 2020 Dec 31, 2019
10-K Annual report Mar 16, 2020 Dec 31, 2019
10-K Annual report Mar 14, 2019 Dec 31, 2018
10-K Annual report Mar 16, 2018 Dec 31, 2017
10-K Annual report Mar 20, 2017 Dec 31, 2016

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
PLSE (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Hayward, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1625101
Former names
Electroblate, Inc. (until Nov 13, 2014)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.